Suppliers / Laboratorio Italiano Biochimico Farmaceutico Lisapharma

Laboratorio Italiano Biochimico Farmaceutico Lisapharma

Italy 33 employees Updated 9 July 2026

Laboratorio Italiano Biochimico Farmaceutico Lisapharma is a finished-dose manufacturer based in Italy. It appears in 56 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with AIFA (IT), EMA and ANPP (DZ). Its GMP standing is certified by EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 26 January 2024 as VAI.

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
56
filings across 7 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 26 January 2024 VAI US FDA
  • 26 September 2023 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
22036- Erba (Co), United Arab Emirates Not on file
Erba, Italy Not on file
Italy, Italy 3008477458

Filings and GMP by regulator

Regulator Filings GMP certificates
AIFA (IT) 29 None
EMA 11 2
ANPP (DZ) 8 None
EDE (AE) 5 None
DAV (Vietnam) 1 None
NMPA (CN) 1 None
US FDA None 1

Comparing suppliers?

Choose your molecules and target markets. Laboratorio Italiano Biochimico Farmaceutico Lisapharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 26 January 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates